Evidence map›Paper›PMID 38686586›Full record

ArticleGenetic epidemiology2024

Identifying somatic fingerprints of cancers defined by germline and environmental risk factors.

Saptarshi Chakraborty, Zoe Guan, Caroline E Kostrzewa, Ronglai Shen, Colin B Begg

Abstract read
In one paragraph

Article in Genetic epidemiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Saptarshi ChakrabortyState University of New York at Buffalo, Buffalo, New York, USA.
Zoe GuanMass General Research Institute, Boston, Massachusetts, USA.
Caroline E KostrzewaMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Ronglai ShenMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Colin B BeggMemorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID 0000-0003-3772-1795

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Project 3P50CA265826 · NCI · DANA-FARBER CANCER INST · PI Daniel Botelho Costa · 2022 to 2026
$13.7M
Harnessing Rare Variants for Tumor ClassificationR01CA251339 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI BEGG, COLIN B, SHEN, RONGLAI · 2021 to 2023
$1.2M
Leveraging the Hidden Genome to Recover the Missing Heritability of CancerR21CA270428 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI BEGG, COLIN B, SHEN, RONGLAI · 2023 to 2023
$455k
NCI NIH HHS P30 CA008748NCI NIH HHS P50 CA265826NCI NIH HHS R01 CA251339NCI NIH HHS R21 CA270428
6 · The paper itself

Abstract

Numerous studies over the past generation have identified germline variants that increase specific cancer risks. Simultaneously, a revolution in sequencing technology has permitted high-throughput annotations of somatic genomes characterizing individual tumors. However, examining the relationship between germline variants and somatic alteration patterns is hugely challenged by the large numbers of variants in a typical tumor, the rarity of most individual variants, and the heterogeneity of tumor somatic fingerprints. In this article, we propose statistical methodology that frames the investigation of germline-somatic relationships in an interpretable manner. The method uses meta-features embodying biological contexts of individual somatic alterations to implicitly group rare mutations. Our team has used this technique previously through a multilevel regression model to diagnose with high accuracy tumor site of origin. Herein, we further leverage topic models from computational linguistics to achieve interpretable lower-dimensional embeddings of the meta-features. We demonstrate how the method can identify distinctive somatic profiles linked to specific germline variants or environmental risk factors. We illustrate the method using The Cancer Genome Atlas whole-exome sequencing data to characterize somatic tumor fingerprints in breast cancer patients with germline BRCA1/2 mutations and in head and neck cancer patients exposed to human papillomavirus.

Indexed as

Breast NeoplasmsGerm-Line MutationBRCA1 ProteinBRCA2 ProteinExome SequencingFemaleGene-Environment InteractionGenetic Predisposition to DiseaseHead and Neck NeoplasmsHumansNeoplasmsPapillomavirus InfectionsRisk FactorsBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, humangermline mutationsgermline‐somatic associationsmeta‐featuresmultilevel regression modelingsomatic mutationstopic models

Identifiers

PMID38686586
PMCPMC11522022

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.